Sabal Serrulatum (Marco Pharma International LLC.)


Welcome to the PulseAid listing for the Sabal Serrulatum drug offered from Marco Pharma International LLC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Marco Pharma International LLC.
NON-PROPRIETARY NAME: Sabal serulatum, Lycopodium clavatum, Pareira brava
SUBSTANCE NAME: SAW PALMETTO; LYCOPODIUM CLAVATUM SPORE; CHONDRODENDRON TOMENTOSUM ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1992-03-01
END MARKETING DATE: 0000-00-00


Sabal Serrulatum HUMAN OTC DRUG Details:

Item DescriptionSabal Serrulatum from Marco Pharma International LLC.
LABELER NAME: Marco Pharma International LLC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1; 4; 4([hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL)
START MARKETING DATE: 1992-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60986-1009_10a9a30e-71d4-4957-b285-122ca9ffadaf
PRODUCT NDC: 60986-1009
APPLICATION NUMBER:

Other SAW PALMETTO; LYCOPODIUM CLAVATUM SPORE; CHONDRODENDRON TOMENTOSUM ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Marco Pharma International LLC.Sabal Serrulatum